APA (7th ed.) Citation

Wagdy M. Eldehna, Sara T. Al-Rashood, Tarfah Al-Warhi, Razan O. Eskandrani, Amal Alharbi, & Ahmed M. El Kerdawy. (2021). Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: Design, synthesis, biological evaluation, and in silico studies. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Wagdy M. Eldehna, Sara T. Al-Rashood, Tarfah Al-Warhi, Razan O. Eskandrani, Amal Alharbi, and Ahmed M. El Kerdawy. Novel Oxindole/benzofuran Hybrids as Potential Dual CDK2/GSK-3β Inhibitors Targeting Breast Cancer: Design, Synthesis, Biological Evaluation, and in Silico Studies. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Wagdy M. Eldehna, et al. Novel Oxindole/benzofuran Hybrids as Potential Dual CDK2/GSK-3β Inhibitors Targeting Breast Cancer: Design, Synthesis, Biological Evaluation, and in Silico Studies. Taylor & Francis Group, 2021.